Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 11.53 | 0.18 | 0.00 | 0.17 |
Total Revenue | 11.53 | 0.18 | 0.00 | 0.17 |
Costof Revenue Total | 10.72 | - | - | - |
Gross Profit | 0.80 | - | - | - |
Selling/ General/ Admin Expenses Total | 0.06 | 0.05 | 0.08 | 0.08 |
Depreciation/ Amortization | 0.00 | - | - | - |
Other Operating Expenses Total | 0.95 | 0.12 | 0.11 | 0.10 |
Total Operating Expense | 11.72 | 0.16 | 0.19 | 0.18 |
Operating Income | -0.20 | 0.02 | -0.19 | -0.02 |
Interest Inc( Exp) Net- Non- Op Total | -0.16 | -0.17 | -0.09 | -0.18 |
Other Net | 0.75 | 0.00 | 0.00 | 0.00 |
Net Income Before Taxes | 0.54 | 0.00 | -0.20 | -0.04 |
Provisionfor Income Taxes | 0.14 | 0.04 | 0.04 | -0.18 |
Net Income After Taxes | 0.40 | -0.04 | -0.23 | 0.14 |
Net Income Before Extra Items | 0.40 | -0.04 | -0.23 | 0.14 |
Net Income | 0.40 | -0.04 | -0.23 | 0.14 |
Income Availableto Com Excl Extra Ord | 0.40 | -0.04 | -0.23 | 0.14 |
Income Availableto Com Incl Extra Ord | 0.40 | -0.04 | -0.23 | 0.14 |
Diluted Net Income | 0.40 | -0.04 | -0.23 | 0.14 |
Diluted Weighted Average Shares | 1.12 | 0.02 | 0.02 | 0.02 |
Diluted EPS Excluding Extra Ord Items | 0.36 | -2.12 | -13.52 | 8.18 |
Diluted Normalized EPS | 0.36 | -2.12 | -13.52 | 8.18 |
Fischer Medical Ventures Dividend Fischer Medical Ventures Bonus Fischer Medical Ventures News Fischer Medical Ventures AGM Fischer Medical Ventures Rights Fischer Medical Ventures Splits Fischer Medical Ventures Board Meetings Fischer Medical Ventures Key Metrics Fischer Medical Ventures Shareholdings Fischer Medical Ventures Balance Sheet Fischer Medical Ventures Cashflow Fischer Medical Ventures Q1 Results Fischer Medical Ventures Q2 Results Fischer Medical Ventures Q3 Results Fischer Medical Ventures Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks